Arcellx Inc (ACLX)
87.22
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
87.15
-0.07
(-0.08%)
After-Hours: 20:00
Arcellx Total Assets (Quarterly): 764.91M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 764.91M |
| June 30, 2024 | 734.31M |
| March 31, 2024 | 779.70M |
| December 31, 2023 | 825.13M |
| September 30, 2023 | 614.22M |
| June 30, 2023 | 623.53M |
| March 31, 2023 | 622.94M |
| Date | Value |
|---|---|
| December 31, 2022 | 313.82M |
| September 30, 2022 | 337.33M |
| June 30, 2022 | 375.33M |
| March 31, 2022 | 243.39M |
| December 31, 2021 | 128.78M |
| September 30, 2021 | 144.96M |
| December 31, 2020 | 57.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
57.69M
Minimum
Dec 2020
825.13M
Maximum
Dec 2023
469.00M
Average
494.77M
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp | 38.08B |
| AbbVie Inc | 143.42B |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 281.89M |
| Shareholders Equity (Quarterly) | 483.02M |
| Current Ratio | 4.286 |